Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Joonsu Han
In vivo metabolic tagging and targeting of circulating red blood cells
Abstract Engineering red blood cells (RBCs) has been widely explored for drug delivery, imaging, vaccination, and other applications. However, effective strategies to directly engineer RBCs in vivo are still lacking. Here, we report successful metabolic glycan labeling of RBCs in vivo. We demonstrate that systemically administered azido-sugars can metabolically label circulating RBCs with azido groups, through labeling of both mature RBCs and RBC precursor cells.
Injectable extracellular vesicle hydrogels with tunable viscoelasticity for depot vaccine - Nature Communications
Abstract Extracellular vesicles (EVs) have been actively explored for therapeutic applications in the context of cancer and other diseases. However, the poor tissue retention of EVs has limited the development of EV-based therapies.
Wireless Magnetic Robot for Precise Hierarchical Control of Tissue Deformation
1 Introduction Mechanotherapy, which functions by applying mechanical forces to injured or diseased tissues, is a promising treatment option for tissue repair and rehabilitation (Figure 1A). Recent advances[1-9] have uncovered the ability of mechanical stimuli to regulate cell proliferation, cell differentiation, and inflammatory responses, thereby facilitating the restoration of injured tissues.
Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines - Nature Communications
Abstract As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking.
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine - Nature Communications
Abstract Dendritic cell (DC) vaccine was among the first FDA-approved cancer immunotherapies, but has been limited by the modest cytotoxic T lymphocyte (CTL) response and therapeutic efficacy. Here we report a facile metabolic labeling approach that enables targeted modulation of adoptively transferred DCs for developing enhanced DC vaccines.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joonsu
Contact Joonsu, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack